UnknownPhase 4

Group A Pharyngitis in Children: The GASPARD Study

Switzerland360 participantsStarted 2017-01-27

Plain-language summary

Evaluate the necessity to treat with antibiotics GAS pharyngitis in children in Switzerland. The null hypothesis is that antibiotic treatment is not necessary for GAS pharyngitis in this population.

Who can participate

Age range3 Years – 15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 3 -15 years old * Clinical symptoms suggestive of pharyngitis with MC Isaac score ≥3 * Rapid-antigen detection test (RADT) positive for GAS- * Signed informed parental/patient consent form Exclusion Criteria: * Hypersensitivity to B-lactams * concomitant disease which must be treated with antibiotics * chronic disease-Immunocompromised * Antibiotics within 72 h * history of ARF,scarlet fever,impetigo,acute glomerulonephritis * Family history of ARF * Complicated pharyngitis

What they're measuring

Non inferiority

Timeframe: up to 1 month

Trial details

NCT IDNCT03264911

SponsorKlara Posfay-Barbe

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12-31

Contact for this trial

Klara Posfay-Barbe

+4122372 5462 klara.posfaybarbe@hcuge.ch

View on ClinicalTrials.gov More Group A Streptococcal Pharyngitis trials